Impaired P50 sensory gating in Machado-Joseph disease

Clinical Neurophysiology

Volumn 115, Issue 10, 2004, Pages 2231-2235

  Ghisolfi, Eduardo S ^a,c,d   Maegawa, Gustavo H B ^e   Becker, Jefferson ^f,g   Paula Zanardo, Ana ^a   Strimitzer Jr , Ivo M ^a   Prokopiuk, Alexandre S ^a   Luiza Pereira, Maria ^a,e   Carvalho, Thiago ^a   Jardim, Laura B ^b,e   Lara, Diogo R ^d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Univ Fed Do R   (Brazil)

^c Campus de Frederico Westphalen   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e Servico Genet Medica Do Hosp C   (Brazil)

^f HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^g Canoas   (Brazil)

Author keywords

Event related potentials; Machado Joseph Disease; P50; Polyglutamine diseases; Sensory gating; Spinocerebellar ataxias

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONDITIONING; CONTROLLED STUDY; EVALUATION; EVOKED AUDITORY RESPONSE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HUMAN; MACHADO JOSEPH DISEASE; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MACHADO-JOSEPH DISEASE; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 4444237449     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2004.04.025     Document Type: Article

References (23)

1. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull. 24:1998;189-202
2. Arpa J., Garcia-Planells J., Soler R., Cruz Martinez A., de Sarria Lucas M.J., Lopez-Pajares R., Gutierrez Molina M., Santiago S., Palau A., Palau F. Spanish family with Machado-Joseph disease: neurophysiological features and neuropathy study. Neurologia. 15:2000;213-221
3. Colding-Jorgensen E., Sorensen S.A., Hasholt L., Lauritzen M. Electrophysiological findings in a Danish family with Machado-Joseph disease. Muscle Nerve. 19:1996;743-750
4. Durr A., Stevanin G., Cancel G., Duyckaerts C., Abbas N., Didierjean O., Chneiweiss H., Benomar A., Lyon-Caen O., Julien J., Serdaru M., Penet C., Agid Y., Brice A. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol. 39:1996;490-499
5. Etchebehere E.C., Cendes F., Lopes-Cendes I., Pereira J.A., Lima M.C., Sansana C.R., Silva C.A., Camargo M.F., Santos A.O., Ramos C.D., Camargo E.E. Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease. Arch Neurol. 58:2001;1257-1263
6. Freedman R., Adler L.E., Waldo M.C., Pachtman E., Franks R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol Psychiatry. 18:1983;537-551
7. Fukutake T., Shinotoh H., Nishino H., Ichikawa Y., Goto J., Kanazawa I., Hattori T. Homozygous Machado-Joseph disease presenting as REM sleep behaviour disorder and prominent psychiatric symptoms. Eur J Neurol. 9:2002;97-100
8. Ghisolfi E.S., Prokopiuk A.S., Becker J., Ehlers J.A., Belmonte-de-Abreu P., Souza D.O., Lara D.R. The adenosine antagonist theophylline impairs P50 auditory sensory gating in normal subjects. Neuropsychopharmacology. 27:2002;629-637
9. Hershman K.M., Freedman R., Bickford P.C. GABAB antagonists diminish the inhibitory gating of auditory response in the rat hippocampus. Neurosci Lett. 190:1995;133-136
10. Jardim L.B., Pereira M.L., Silveira I., Ferro A., Sequeiros J., Giugliani R. Neurologic findings in Machado-Joseph Disease, relation with disease duration, subtypes and (CAG)n. Arch Neurol. 58:2001;899-904
11. Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M., Katayama S., Kawakami H., Nakamura S., Nishimura M., Akiguchi I., Kimura J., Narumiya S., Kakizuka A. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet. 8:1994;221-228
12. Kondo H., Harayama H., Shinozawa K., Yuasa T., Miyatake T. Auditory brainstem response and somatosensory evoked potential in Machado-Joseph disease in Japanese families. Rinsho Shinkeigaku. 30:1990;723-727
13. Light G.A., Malaspina D., Geyer M.A., Luber B.M., Coleman E.A., Sackeim H.A., Braff D.L. Amphetamine disrupts P50 suppression in normal subjects. Biol Psychiatry. 46:1999;990-996
14. Light G.A., Geyer M.A., Clementz B.A., Cadenhead K.S., Braff D.L. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry. 157:(5):2000;767-771
15. Murata Y., Yamaguchi S., Kawakami H., Imon Y., Maruyama H., Sakai T., Kazuta T., Ohtake T., Nishimura M., Saida T., Chiba S., Oh-i T., Nakamura S. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol. 55:1998;33-37
16. Nakano K.K., Dawson D.M., Spence A. Machado disease. A hereditary ataxiain Portuguese emigrants to Massachussetts. Neurology. 22:1972;49
17. Radvany J., Camargo C.H., Costa Z.M., Fonseca N.C., Nascimento E.D. Machado-Joseph disease of Azorean ancestry in Brazil: the Catarina kindred. Neurological, neuroimaging, psychiatric and neuropsychological findings in the largest known family, the "Catarina" kindred. Arq Neuropsiquiatr. 51:1993;21-30
18. Rosenberg R.N., Nyhan W.L., Bay C., Shore P. Autosomal dominant striatonigral degeneration. Neurology. 26:1976;703-714
19. Sequeiros J., Coutinho P. Epidemiology and clinical aspects of Machado-Joseph disease. Harding A., Deufel T., Chamber-lain S. Hereditary ataxias. Adv Neurol. vol. 61:1993;139-153 Raven Press, New York
20. Takegosh H., Murofushi T. Vestibular evoked myogenic potentials in patients with spinocerebellar degeneration. Acta Otolaryngol. 120:(7):2000;821-824
21. Takiyama Y., Nishizawa M., Tanaka H., Kawashima S., Sakamoto H., Karube Y., Shimazaki H., Soutome M., Endo K., Ohta S., Kagawa Y., Kanazawa I., Mizuno Y., Yoshida M., Yuasa T., Horikawa Y., Oyanagi K., Nagai H., Kondo T., Inuzuka T., Onodera O., Tsuji S. The gene for Machado-Joseph disease maps to human chromosome 14q. Nature Genet. 4:1993;300-303
22. Woods B.T., Schaumburg H.H. Nigro-spino-dentatal degeneration with nuclear ophtalmoplegia. A unique and partially treatable clinico- pathologicalentity. J Neurol Sci. 17:1972;149-166
23. Yamamoto M., Kachi T., Sobue G. Pain-related and electrically stimulated somatosensory evoked potentials in patients with Machado-Joseph disease and multiple system atrophy. Intern Med. 36:1997;550-555